BioSherpa's™ value proposition is threefold:
Diagnostic Accuracy
By delivering reliable, accurate culture results even in antibiotic treated patients, BioSherpa™ STS facilitates a range of therapeutic interventions including sepsis protocols and other infection control mandates.
Improved Antibiotic Stewardship
BioSherpa™ STS has the ability to improve diagnostic results, which promote the move from broad spectrum to targeted antibiotic therapy.
Creates Real Infectious Disease Value-added
BioSherpa™ STS can improve diagnostic specificity, financials, and Case Mix Index (CMI) while simultaneously decreasing antibiotic-related adverse events and observed/expected mortality metrics.